Dr. Lurong Pan | Protein LLM and Generative AI in protein engineering
Foresight Institute Molecular Machines Group
Protein LLM and Generative AI in protein engineering
Dr. Lurong Pan, CEO and founder of Ainnocence, possesses over 15 years of expertise in computational drug design. Her educational background includes an applied chemistry degree from Nanjing University, a master’s in artificial intelligence from Georgia Tech, a PhD in computational chemistry with postdoctoral research in structural biology from the University of Alabama at Birmingham(UAB). Dr. Pan was the Director of computational sciences of the Integrated System Center at UAB, enhancing interdisciplinary biomedical research. She also served as a Senior Investigator at the Global Health Drug Discovery Institute, a collaboration between the Bill & Melinda Gates Foundation and Tsinghua University, focusing on AI-driven drug discovery for global health. In 2021, Dr. Pan established Ainnocence, introducing an innovative, energy-efficient AI platform to transform early drug discovery, specializing in small molecule and biologics drug design and optimization.
Foresight Institute Molecular Machines Group
This seminar is part of Foresight's Molecular Machines Seminar Series. To join future seminars in this program please apply here.
A group of scientists, entrepreneurs, and institutional allies who cooperate to advance molecular machines, applications in energy, medicine, and material science, and long-term progress toward Richard Feynman’s vision of nanotechnology.
Nominate a seminar presenter/topic
Feel free to reach out to lydia@foresight.org with any questions.